Q&A: Blackstone Life Sciences head on drug R&D in Asia
Blackstone Life Sciences head Nicholas Galakatos talks regulation and the drug R&D process, and explains how investors can avoid mistakes in the pharmaceutical gold rush.
October 01, 2019
